

<!-- Generated by DataTracks version 1.0.8 on 03-Nov-2013 [02:40:25] {AM} EST - www.datatracks.com -->
<schema targetNamespace="http://acurapharm.com/20130930" elementFormDefault="qualified" xmlns:acur="http://acurapharm.com/20130930" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://acurapharm.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>101 - Document - Document And Entity Information</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>102 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedStatementsOfOperationsAndComprenesiveIncomeLoss" id="ConsolidatedStatementsOfOperationsAndComprenesiveIncomeLoss">
        <link:definition>104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPRENESIVE INCOME (LOSS)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
        <link:definition>105 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#39; EQUITY</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical" id="ConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>106 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#39; EQUITY (Parenthetical)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" id="ConsolidatedStatementsOfCashFlowsParenthetical">
        <link:definition>108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/DescriptionOfBusinessAndPresentation" id="DescriptionOfBusinessAndPresentation">
        <link:definition>109 - Disclosure - DESCRIPTION OF BUSINESS AND PRESENTATION</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ResearchAndDevelopmentActivities" id="ResearchAndDevelopmentActivities">
        <link:definition>110 - Disclosure - RESEARCH AND DEVELOPMENT ACTIVITIES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/RevenueRecognition" id="RevenueRecognition">
        <link:definition>111 - Disclosure - REVENUE RECOGNITION</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/LicenseDevelopmentAndCommercializationAgreement" id="LicenseDevelopmentAndCommercializationAgreement">
        <link:definition>112 - Disclosure - LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENT</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>113 - Disclosure - INCOME TAXES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/InvestmentsInMarketableSecurities" id="InvestmentsInMarketableSecurities">
        <link:definition>114 - Disclosure - INVESTMENTS IN MARKETABLE SECURITIES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/Inventories" id="Inventories">
        <link:definition>115 - Disclosure - INVENTORIES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>116 - Disclosure - ACCRUED EXPENSES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/SharebasedCompensation" id="SharebasedCompensation">
        <link:definition>117 - Disclosure - SHARE-BASED COMPENSATION</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/EquityFinancing" id="EquityFinancing">
        <link:definition>118 - Disclosure - EQUITY FINANCING</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/CommonStockWarrants" id="CommonStockWarrants">
        <link:definition>119 - Disclosure - COMMON STOCK WARRANTS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/EarningsPerShareEps" id="EarningsPerShareEps">
        <link:definition>120 - Disclosure - EARNINGS PER SHARE (&#34;EPS&#34;)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>121 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/InvestmentsInMarketableSecuritiesTables" id="InvestmentsInMarketableSecuritiesTables">
        <link:definition>122 - Disclosure - INVESTMENTS IN MARKETABLE SECURITIES (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <link:definition>123 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/SharebasedCompensationTables" id="SharebasedCompensationTables">
        <link:definition>124 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/EarningsPerShareEpsTables" id="EarningsPerShareEpsTables">
        <link:definition>125 - Disclosure - EARNINGS PER SHARE (&#34;EPS&#34;) (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ResearchAndDevelopmentActivitiesAdditionalInformationDetail" id="ResearchAndDevelopmentActivitiesAdditionalInformationDetail">
        <link:definition>126 - Disclosure - Research and Development Activities - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/RevenueRecognitionAdditionalInformationDetail" id="RevenueRecognitionAdditionalInformationDetail">
        <link:definition>127 - Disclosure - Revenue Recognition - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/LicenseDevelopmentAndCommercializationAgreementAdditionalInformationDetail" id="LicenseDevelopmentAndCommercializationAgreementAdditionalInformationDetail">
        <link:definition>128 - Disclosure - License Development and Commercialization Agreement - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/IncomeTaxesAdditionalInformationDetail" id="IncomeTaxesAdditionalInformationDetail">
        <link:definition>129 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/SummaryOfInvestmentInMarketableSecuritiesDetail" id="SummaryOfInvestmentInMarketableSecuritiesDetail">
        <link:definition>130 - Disclosure - Summary of Investment in Marketable Securities (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail" id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail">
        <link:definition>131 - Disclosure - Available for Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisDetail" id="AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisDetail">
        <link:definition>132 - Disclosure - Assets Measured at Fair Value or Disclosed at Fair Value on Recurring Basis (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/InvestmentInMarketableSecuritiesAdditionalInformationDetail" id="InvestmentInMarketableSecuritiesAdditionalInformationDetail">
        <link:definition>133 - Disclosure - Investment In Marketable Securities - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/InventoriesAdditionalInformationDetail" id="InventoriesAdditionalInformationDetail">
        <link:definition>134 - Disclosure - Inventories - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/AccruedExpensesDetail" id="AccruedExpensesDetail">
        <link:definition>135 - Disclosure - Accrued Expenses (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/RecognitionOfSharebasedCompensationExpenseDetail" id="RecognitionOfSharebasedCompensationExpenseDetail">
        <link:definition>136 - Disclosure - Recognition of Share-Based Compensation Expense (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/StockOptionAwardActivityDetail" id="StockOptionAwardActivityDetail">
        <link:definition>137 - Disclosure - Stock Option Award Activity (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/AssumptionsUsedInBlackscholesModelToDetermineFairValueForStockOptionAwardsGrantedDetail" id="AssumptionsUsedInBlackscholesModelToDetermineFairValueForStockOptionAwardsGrantedDetail">
        <link:definition>138 - Disclosure - Assumptions Used in Black-Scholes Model to Determine Fair Value for Stock Option Awards Granted (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/SummaryOfRsuPlanDetail" id="SummaryOfRsuPlanDetail">
        <link:definition>139 - Disclosure - Summary of RSU Plan (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/SharebasedCompensationAdditionalInformationDetail" id="SharebasedCompensationAdditionalInformationDetail">
        <link:definition>140 - Disclosure - Share-Based Compensation - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/EquityFinancingAdditionalInformationDetail" id="EquityFinancingAdditionalInformationDetail">
        <link:definition>141 - Disclosure - Equity Financing - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/CommonStockWarrantsAdditionalInformationDetail" id="CommonStockWarrantsAdditionalInformationDetail">
        <link:definition>142 - Disclosure - Common Stock Warrants - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/ReconciliationOfNumeratorsAndDenominatorsOfBasicAndDilutedEpsDetail" id="ReconciliationOfNumeratorsAndDenominatorsOfBasicAndDilutedEpsDetail">
        <link:definition>143 - Disclosure - Reconciliation of Numerators and Denominators of Basic and Diluted EPS (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://acurapharm.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" id="CommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>144 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:linkbaseRef xlink:type="simple" xlink:href="acur-20130930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="acur-20130930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="acur-20130930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="acur-20130930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>

  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />

  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />

  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />

  <import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/exch/2013-01-31" schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />

  <import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />

  <import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd" />

  <element name="ResearchAndDevelopmentActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ResearchAndDevelopmentActivitiesAbstract" />

  <element name="ResearchAndDevelopmentActivitiesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ResearchAndDevelopmentActivitiesTextBlock" />

  <element name="RevenueRecognitionMultipleDeliverableArrangementsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_RevenueRecognitionMultipleDeliverableArrangementsTextBlock" />

  <element name="ResearchAndDevelopmentDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ResearchAndDevelopmentDisclosureAbstract" />

  <element name="ResearchAndDevelopmentDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ResearchAndDevelopmentDisclosureTextBlock" />

  <element name="InvestmentsMarketableSecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_InvestmentsMarketableSecuritiesAbstract" />

  <element name="InvestmentsMarketableSecuritiesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_InvestmentsMarketableSecuritiesTableTextBlock" />

  <element name="EquityFinancingTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_EquityFinancingTextBlock" />

  <element name="AccruedResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_AccruedResearchAndDevelopmentExpenseCurrent" />

  <element name="PaymentOfRoyaltyMaximumContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PaymentOfRoyaltyMaximumContractualTerm" />

  <element name="DisclosureLicenseDevelopmentAndCommercializationAgreementAdditionalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureLicenseDevelopmentAndCommercializationAgreementAdditionalInformationAbstract" />

  <element name="LicenseDevelopmentAndCommercializationAgreementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_LicenseDevelopmentAndCommercializationAgreementTable" />

  <element name="PivotalPhaseIiiClinicalStudyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PivotalPhaseIiiClinicalStudyMember" />

  <element name="FdasApprovalMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_FdasApprovalMember" />

  <element name="PercentageOfRoyalty" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PercentageOfRoyalty" />

  <element name="PercentageOfRoyaltyDeductToSettleThirdPartyClaim" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PercentageOfRoyaltyDeductToSettleThirdPartyClaim" />

  <element name="PercentageOfRoyaltyOfRoyaltyPayableMinimum" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PercentageOfRoyaltyOfRoyaltyPayableMinimum" />

  <element name="RoyaltyPaymentObligationExpirationDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_RoyaltyPaymentObligationExpirationDescription" />

  <element name="PatentsExpirationYear" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PatentsExpirationYear" />

  <element name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_IncomeTaxDisclosureTable" />

  <element name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_IncomeTaxDisclosureLineItems" />

  <element name="OperatingLossCarryForwardsExpirationYear" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_OperatingLossCarryForwardsExpirationYear" />

  <element name="InvestmentInMarketableSecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_InvestmentInMarketableSecuritiesAbstract" />

  <element name="MarketableSecuritiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_MarketableSecuritiesTable" />

  <element name="PooledInvestmentFundMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PooledInvestmentFundMember" />

  <element name="InvestmentInMarketableSecuritiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_InvestmentInMarketableSecuritiesLineItems" />

  <element name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTable" />

  <element name="CorporateBondsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CorporateBondsMember" />

  <element name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueLineItems" />

  <element name="AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisAbstract" />

  <element name="AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisTable" />

  <element name="AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_AssetsMeasuredAtFairValueOrDisclosedAtFairValueOnRecurringBasisLineItems" />

  <element name="InvestmentInMarketableSecuritiesAdditionalInformationDetailAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_InvestmentInMarketableSecuritiesAdditionalInformationDetailAbstract" />

  <element name="InvestmentInMarketableSecuritiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_InvestmentInMarketableSecuritiesTable" />

  <element name="ScheduleOfInventoryTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_ScheduleOfInventoryTable" />

  <element name="DisclosureAccruedExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureAccruedExpensesAbstract" />

  <element name="AccountsPayableAndAccruedLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_AccountsPayableAndAccruedLiabilitiesTable" />

  <element name="AccountsPayableAndAccruedLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_AccountsPayableAndAccruedLiabilitiesLineItems" />

  <element name="OtherAccruedTaxesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_OtherAccruedTaxesCurrent" />

  <element name="ManufacturingServicesCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_ManufacturingServicesCosts" />

  <element name="AccruedOtherProfessionalFeesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_AccruedOtherProfessionalFeesCurrent" />

  <element name="DisclosureNonCashShareBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureNonCashShareBasedCompensationExpenseAbstract" />

  <element name="DisclosureStockOptionAwardActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureStockOptionAwardActivityAbstract" />

  <element name="StockOptionPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_StockOptionPlanMember" />

  <element name="DisclosureAssumptionsUsedInBlackScholesModelToDetermineFairValueForStockOptionAwardsGrantedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureAssumptionsUsedInBlackScholesModelToDetermineFairValueForStockOptionAwardsGrantedAbstract" />

  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExpectedForfeitures" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExpectedForfeitures" />

  <element name="SummaryOfInformationAboutNonVestedStockOptionsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_SummaryOfInformationAboutNonVestedStockOptionsDisclosureAbstract" />

  <element name="RsusMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_RsusMember" />

  <element name="VestedRestrictedStockUnitsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_VestedRestrictedStockUnitsMember" />

  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsDistributedInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsDistributedInPeriod" />

  <element name="CostOfSalesExcludingInventoryWriteDown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="acur_CostOfSalesExcludingInventoryWriteDown" />

  <element name="FourZeroOneKAndProfitSharingPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_FourZeroOneKAndProfitSharingPlanMember" />

  <element name="OptionPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_OptionPlanMember" />

  <element name="NumberOfStockIncentivePlans" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="acur_NumberOfStockIncentivePlans" />

  <element name="TaxesWithheldOnIssuanceOfStockBasedAwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="acur_TaxesWithheldOnIssuanceOfStockBasedAwards" />

  <element name="StockIssuedDuringPeriodSharesStockOptionsExercisedNetOfSharesForTaxWithholdings" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_StockIssuedDuringPeriodSharesStockOptionsExercisedNetOfSharesForTaxWithholdings" />

  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionAwardsDistributedPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionAwardsDistributedPercentage" />

  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedInPeriod" />

  <element name="EquityFinancingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_EquityFinancingTable" />

  <element name="AgreementWithMlvAndCoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_AgreementWithMlvAndCoMember" />

  <element name="EquityFinancingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_EquityFinancingLineItems" />

  <element name="SaleOfStockNumberSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_SaleOfStockNumberSharesIssued" />

  <element name="ProceedsFromMarketOfferingOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_ProceedsFromMarketOfferingOfShares" />

  <element name="ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings" />

  <element name="DisclosureCommonStockWarrantsAdditionalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureCommonStockWarrantsAdditionalInformationAbstract" />

  <element name="ExercisePriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="acur_ExercisePriceOfWarrants" />

  <element name="ClassOfWarrantOrRightExpirationDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="acur_ClassOfWarrantOrRightExpirationDate" />

  <element name="EarningPerShareBasicNumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_EarningPerShareBasicNumeratorAbstract" />

  <element name="CommonStockIssuableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CommonStockIssuableAbstract" />

  <element name="DisclosureCommitmentsAndContingenciesAdditionalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DisclosureCommitmentsAndContingenciesAdditionalInformationAbstract" />

  <element name="CommitmentsAndContingenciesDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="acur_CommitmentsAndContingenciesDisclosureTable" />

  <element name="RestrictedStockUnitAwardPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_RestrictedStockUnitAwardPlanMember" />

  <element name="ElectionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_ElectionsMember" />

  <element name="OtherElectionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_OtherElectionsMember" />

  <element name="LocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="acur_LocationAxis" />

  <element name="PennsylvaniaStateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PennsylvaniaStateMember" />

  <element name="NewJerseyStateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_NewJerseyStateMember" />

  <element name="CaliforniaStateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CaliforniaStateMember" />

  <element name="PalatineLllinoisMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PalatineLllinoisMember" />

  <element name="FinancialAdvisorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_FinancialAdvisorMember" />

  <element name="CommitmentsAndContingenciesDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CommitmentsAndContingenciesDisclosureLineItems" />

  <element name="NumberOfLawsuitsFiled" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="acur_NumberOfLawsuitsFiled" />

  <element name="NumberOfLawsuitsServed" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="acur_NumberOfLawsuitsServed" />

  <element name="PercentageOfFeeAssumedOnExerciseOfWarrantsInUnitOffering" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PercentageOfFeeAssumedOnExerciseOfWarrantsInUnitOffering" />

  <element name="CashlessMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CashlessMember" />

  <element name="OptionNonCashExerciseOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_OptionNonCashExerciseOneMember" />

  <element name="SharesWithheldForTaxShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_SharesWithheldForTaxShares" />

  <element name="SharesWithheldForTaxValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="acur_SharesWithheldForTaxValue" />

  <element name="IssuanceOfCommonStockSharesUnderMarketOfferings" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_IssuanceOfCommonStockSharesUnderMarketOfferings" />

  <element name="IssuanceOfCommonStockValueUnderMarketOfferings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_IssuanceOfCommonStockValueUnderMarketOfferings" />

  <element name="ProvisionToReduceInventoryToNetRealizableValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="acur_ProvisionToReduceInventoryToNetRealizableValue" />

  <element name="CashPaidDuringPeriodForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CashPaidDuringPeriodForAbstract" />

  <element name="RestrictedStockUnitMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_RestrictedStockUnitMember" />

  <element name="EquityBasedEmployeeCompensationGrantedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_EquityBasedEmployeeCompensationGrantedShares" />

  <element name="CommonStockWithheldShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CommonStockWithheldShares" />

  <element name="EquityIssuanceCostsWithheld" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="acur_EquityIssuanceCostsWithheld" />

  <element name="SharesWithheldToSatisfyEmployeesTaxWithholdingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_SharesWithheldToSatisfyEmployeesTaxWithholdingShares" />

  <element name="SupplementalTaxWithholding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="acur_SupplementalTaxWithholding" />

  <element name="CommonStockIssuedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_CommonStockIssuedShares" />

  <element name="DescriptionOfBusinessDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DescriptionOfBusinessDisclosureAbstract" />

  <element name="LicenseDevelopmentAndCommercializationAgreementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_LicenseDevelopmentAndCommercializationAgreementLineItems" />

  <element name="SettlementAgreementWithParMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_SettlementAgreementWithParMember" />

  <element name="PfizerAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_PfizerAgreementMember" />

  <element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="acur_DocumentAndEntityInformationAbstract" />

  <element name="PrepaidResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="acur_PrepaidResearchAndDevelopmentExpenseCurrent" />
</schema>






